Skip to main content

BioForce Nanosciences, French Researchers to Collaborate on Neural Cell-based Assays

NEW YORK (GenomeWeb News) – BioForce Nanosciences today said that it will collaborate with researchers from the University Pierre & Marie Curie and the Centre National de Recherche Scientifique to develop technologies, protocols, and products related to neural cell-based assays.
The assays will be created using BioForce’s Nano eNabler molecular printer, which will allow scientists to study the structure, function, and microenvironments of neural cells. The Ames, Iowa-based firm said that neural cell-based assays hold “great promise” for evaluating the potential of new drug compounds for treating neurodegenerative diseases and neural trauma.
"This novel molecular microprinting device appears to be a very useful and flexible technology to bring new insights into the cellular response processes, such as proliferation, apoptosis, morphogenesis, and differentiation,” Fatiha Nothias, principal investigator at UPMC, said in a statement.
Financial and other terms of the collaboration were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.